Tue, Jul 29, 2014, 5:10 AM EDT - U.S. Markets open in 4 hrs 20 mins


% | $
Click the to save as a favorite.

Prima Biomed Ltd. Message Board

  • drivrbenz drivrbenz Oct 18, 2012 11:40 PM Flag

    Drug Pipeline

    Prima Biomed has two programs in place. The lead program, CVac™ has completed phase II clinical trials and focuses on the development of an ex-vivo immunotherapy for ovarian cancer. Prima is currently undertaking a Phase IIb clinical study in the US and Australia, and has commenced a global phase II/III program in 2012, with a goal to commercialize CVac™ in multiple world markets.

    The second program is a collaborative venture with the University of New South Wales and University of Queensland to create a technology enabling oral administration of vaccines that are currently injected. The lead target for this program is to create an oral vaccine against Human Papilloma Virus (HPV), a virus associated with development of cervical cancer.

1.120.00(0.00%)Jul 28 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.